APPLICATION
ANDA211959
TYPE
ANDA
ORIGINAL APPROVAL
2020-12-09
LATEST ACTION
2023-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CLOBAZAMDiscontinued
CLOBAZAM 20MG · TABLET · ORAL
CLOBAZAMDiscontinued
CLOBAZAM 10MG · TABLET · ORAL
Approval history
2023-05-01Labeling · Supplement 3 · standardAP
2021-11-08Labeling · Supplement 1 · standardAP
2020-12-09UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.